However, reduced‐HMGB1 exerts no considerable effect on these inflammatory mediators (Frank et al., 2016), suggesting that HMGB1 may not be a key mediator of intracranial inflammation in the ultra‐early phase of cerebral infarction. Here, HMGB1 is linked to brain infarction.